|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Spironolactone in type 2 diabetic nephropathy : effects on proteinuria, blood pressure and renal function显示文摘 | Meiracker A H Baggen R G Pauli S | 2006 | J of Hypertension2006，24，11： | 1 |
| 2 | The most recent study into blood pressure lowering by amlodipine:the beginning of the end for the beta-blockers 显示文摘 | van den Meiracker AH van Monffrans GA | 2006 | Ned Tijdsehr Geneeskd2006，150，： | 1 |
| 3 | Plasma A- and B-type nat- riuretic peptides: physiology, methodology and clinical use 显示文摘 | Boomsma F van den Meiracker AH | 2001 | CardiovascRes2001，51，3： | 1 |
| 4 | Plasma A and B-type natriuretic peptide:physiology,methodology and clinical use显示文摘 | Boomsma F van den Meiracker AH | 2001 | Cardiovasc Res2001，51，： | 1 |
| 5 | Arterial stiffness,cardiovagal baroreflex sensitivity and postural blood pressure changes in older adults:the Rotterdam Study显示文摘 | Mattace Raso FU van den Meiracker AH Bos WJ | 2007 | J Hypertens2007，25，： | 1 |
| 6 | Causes and consequences of a non-dipping blood pressure profile 显示文摘 | Birkenhager AM van den Meiracker AH | 2007 | Neth J Med2007，65，4： | 1 |
| 7 | Aldosterone-to-renin ratio as a screening test for primary aldosteronism - the Dutch ARRAT Study 显示文摘 | Jansen PM Boomsma F van den Meiracker AH | 2008 | Neth J Med2008，66，5： | 1 |
| 8 | Spectral analysis of heart rate and blood pressure variability in primary Sjoegren's Syndrome 显示文摘 | Barendregt PJ Tulen JH Van Den Meiracker AH | 2002 | Ann Rheum Dis2002，61，3： | 1 |
| 9 | Plasma A-and B-type natriuretic peptides:physiology,methodology and clinical use显示文摘 | Boomsma F van den Meiracker AH | 2001 | Cardiovasc Res2001，51，3： | 1 |
| 10 | Spironolactone in type 2 diabetic nephropathy : effects on proteinuria, blood pressure and renal function 显示文摘 | van den Meiracker AH Baggen RG Pauli S | 2006 | J Hypertens2006，24，11： | 1 |
| 11 | Para- ganglioma of the urinary bladder 显示文摘 | Kappers MH van den Meiracker AH Alwani RA | 2008 | Neth J Med2008，66，： | 1 |
| 12 | Partial escape of angiotensin converting enzyme (ACE)inhibition during prolonged ACE inhibitor treatment:does it exist and does it affect the antihypertensive response?显示文摘 | Van den Meiracker AH Man in 't Veld AJ Admiraal PJ | 1992 | J Hypertens1992，10，8： | 1 |
| 13 | Plasma A-and B-type natriuretic peptides; physiology, methodology and clinical use 显示文摘 | Boomsma F van den Meiracker AH | 2001 | Cardiovase Res2001，51，3： | 1 |
| 14 | Diurnal blood pressure variation in progressive autonomic failure显示文摘 | Carvalho MJ Van Den Meiracker AH Boomsma F | 2000 | Hypertension2000，35，： | 1 |
| 15 | Role of endothelin in preeclampsia and hypertension following antiangiogenesis treatment显示文摘 | Saleh L Danser JA van den Meiracker AH | 2016 | Curr Opin Nephrol Hypertens2016，25，2： | 1 |
| 16 | Plasma A-and B-type na-triuretic peptides:physiology,methodology and clinical use显示文摘 | Boomsma F Van den Meiracker AH | 2001 | Cardiovasc Res2001，51，3： | 1 |
| 17 | Circulating semicarbazide-sensitive amine oxidase is raised both in type I ( insulin-dependent), in type l] (non-insulin-dependent) diabetes mellitus and even in childhood type I diabetes at first clinical diagnosis 显示文摘 | Boomsma F van den Meiracker AI-I Winkel S | 1999 | Diabetologia1999，42，2： | 1 |
| 18 | Plasma A- and B-type natriuretic peptides:physiology,methodology and clinical use显示文摘 | Boomsma F van den Meiracker AH | 2001 | Cardiovasc Res2001，51，： | 1 |
| 19 | Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function显示文摘 | Van den Meiracker AH Baggeu RG Pauli S | 2006 | J Hypertens2006，24，11： | 1 |
| 20 | Diagnostic and prognostic value of B-type natriuretic peptides in heart failure or signs of heart failure 显示文摘 | Rutten JH Boomsma F Van den Meiracker AH | 2007 | Ned Tijdschr Geneeskd2007，151，46： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员